ETX — E-Therapeutics Share News
0.000.00%
- £54.93m
- £23.53m
- £0.48m
REG - e-Therapeutics plc - Holding(s) in Company
AnnouncementREG - e-Therapeutics plc - Result of AGM
AnnouncementREG - e-Therapeutics plc - Senior Management Appointment and Options Grant
AnnouncementREG - e-Therapeutics plc - Notice of AGM and Posting of Annual Report
AnnouncementREG - e-Therapeutics plc - Results of conditional Fundraise to raise £22.5m
AnnouncementREG - e-Therapeutics plc - Retail Offer
AnnouncementREG - e-Therapeutics plc - Proposed Fundraise in excess of £20 million
AnnouncementREG - e-Therapeutics plc - Final Results for the Year Ended 31 January 2021
AnnouncementREG - e-Therapeutics plc - Notification of Full Year Results Date
AnnouncementREG - e-Therapeutics plc - ETX to receive two payments from Galapagos
AnnouncementREG - e-Therapeutics plc - Appointment of Chief Financial Officer
AnnouncementREG - e-Therapeutics plc - Board Changes
AnnouncementREG - e-Therapeutics plc - Change of Adviser
AnnouncementREG - e-Therapeutics plc - Holding(s) in Company
AnnouncementRCS - e-Therapeutics plc - e-therapeutics to present at Shares Evening
AnnouncementREG - e-Therapeutics plc - Holding(s) in Company
AnnouncementREG - e-Therapeutics plc - RNA Therapeutics Platform
AnnouncementREG - e-Therapeutics plc - Second Price Monitoring Extn
AnnouncementREG - e-Therapeutics plc - Price Monitoring Extension
Announcement